Manhapra A - Search Results

1

Pediatric uveitis: A comprehensive review.

Maleki A, Anesi SD, Look-Why S, Manhapra A, Foster CS. Maleki A, et al. Among authors: manhapra a. Surv Ophthalmol. 2022 Mar-Apr;67(2):510-529. doi: 10.1016/j.survophthal.2021.06.006. Epub 2021 Jun 25. Surv Ophthalmol. 2022. PMID: 34181974 Review.

2

Fixed-Luminance and Multi-Luminance Flicker Electroretinography Parameters in Patients with Early Active Birdshot Chorioretinopathy.

Maleki A, Ueberroth JA, Manhapra A, Walsh M, Asgari S, Chang PY, Anesi SD, Foster CS. Maleki A, et al. Among authors: manhapra a. Ocul Immunol Inflamm. 2022 Jan 2;30(1):129-135. doi: 10.1080/09273948.2020.1797113. Epub 2020 Aug 20. Ocul Immunol Inflamm. 2022. PMID: 32816569

3

Diagnostic and Prognostic Roles of Serum Interleukin-6 Levels in Patients with Uveitis.

Maleki A, Gomez S, Asgari S, Bosenberg Z, Manhapra A, Walsh M, Weng A, Tsang C, He C, Anesi SD, Foster CS. Maleki A, et al. Among authors: manhapra a. Ocul Immunol Inflamm. 2022 Feb 17;30(2):457-462. doi: 10.1080/09273948.2020.1815799. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2022. PMID: 32965154

4

Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis.

Maleki A, Manhapra A, Asgari S, Chang PY, Foster CS, Anesi SD. Maleki A, et al. Among authors: manhapra a. Ocul Immunol Inflamm. 2021 Jan 2;29(1):14-20. doi: 10.1080/09273948.2020.1817501. Epub 2020 Oct 6. Ocul Immunol Inflamm. 2021. PMID: 33021415 Review.

5

Vascular abnormalities in uveitis.

Ebrahimiadib N, Maleki A, Fadakar K, Manhapra A, Ghassemi F, Foster CS. Ebrahimiadib N, et al. Among authors: manhapra a. Surv Ophthalmol. 2021 Jul-Aug;66(4):653-667. doi: 10.1016/j.survophthal.2020.12.006. Epub 2021 Jan 5. Surv Ophthalmol. 2021. PMID: 33412171 Review.

6

Chlorambucil combination therapy in refractory serpiginous choroiditis: A cure?

Maleki A, Maldonado Cerda A, Garcia CM, Zein M, Manhapra A, Foster CS. Maleki A, et al. Among authors: manhapra a. Am J Ophthalmol Case Rep. 2021 Jan 30;21:101014. doi: 10.1016/j.ajoc.2021.101014. eCollection 2021 Mar. Am J Ophthalmol Case Rep. 2021. PMID: 33615036 Free PMC article.

7

Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) after Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage.

Maleki A, Garcia CM, Asgari S, Manhapra A, Foster CS. Maleki A, et al. Among authors: manhapra a. Ocul Immunol Inflamm. 2022 Jul;30(5):1099-1108. doi: 10.1080/09273948.2020.1869787. Epub 2021 Mar 1. Ocul Immunol Inflamm. 2022. PMID: 33646065

8

Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis.

Lin M, Anesi SD, Chang PY, Eggenschwiler L, Manhapra A, Walsh M, Foster CS. Lin M, et al. Among authors: manhapra a. Can J Ophthalmol. 2022 Jun;57(3):207-213. doi: 10.1016/j.jcjo.2021.03.001. Epub 2021 Apr 7. Can J Ophthalmol. 2022. PMID: 33838140

9

Clinical course and poor prognostic factors of Vogt-Koyanagi-Harada disease in a tertiary uveitis clinic.

Maleki A, Anesi SD, Look-Why S, Asgari S, Manhapra A, Foster CS. Maleki A, et al. Among authors: manhapra a. Can J Ophthalmol. 2022 Apr;57(2):142-144. doi: 10.1016/j.jcjo.2021.04.005. Epub 2021 May 10. Can J Ophthalmol. 2022. PMID: 33984288 No abstract available.

10

Acquired Vitelliform-Like Lesion in Uveitis: A case-series.

Maleki A, Look-Why S, Asgari S, Manhapra A, Gomez S, Foster CS. Maleki A, et al. Among authors: manhapra a. Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):2027-2036. doi: 10.1080/09273948.2021.1954201. Epub 2021 Jul 27. Ocul Immunol Inflamm. 2022. PMID: 34314305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page